Bacterial meningitis infection in a mammal is treated by intravenous infusion of therapeutically effective amounts of monoclonal antibodies which bind to tumor necrosis factor alpha. Treatment can be initiated up to five hours after bacterial challenge and is preferably in combination with an antibiotic...
1986. Use of monoclonal antibodies in the indirect fluorescent antibody technique (IFA) for the diagnosis of Edwardsiella ictaluri. J. Fish Dis. 9: 439-444.Ainsworth J, Capley G, Waterstreet P, Munson D. Use of monoclonal antibodies in the indirect fluorescent antibody technique (IFA) for ...
This novel method of drug delivery circumvents the need for monoclonal antibodies, and more investigation of the system may allow a controlled clinical study of its effectiveness. 展开 关键词: Transferrin adriamycin transferrin receptors redox reactions diferric transferrin reductase NADH oxidase ligand ...
Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , HLA-C locus products may be associated only weakly with B2m, explaining some of the difficulties encountered in biochemical studies of HLA-C antigens... NJ ...
戊戌数据药品标准数据库提供了Monoclonal antibodies for human use欧洲药典标准的查询检索,包括Monoclonal antibodies for human use欧洲药典的版本EP9.0页码,以及药典的查询与下载.
Use of antagonist anti-CD40 monoclonal antibodies for treatment of chronic lymphocytic leukemiaMethods of therapy for treating a subject for an autoimmune disease and/or inflammatory disease are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 ...
戊戌数据药品标准数据库提供了Monoclonal antibodies for human use欧洲药典标准的查询检索,包括Monoclonal antibodies for human use欧洲药典的版本EP10.0页码,以及药典的查询与下载.
Monoclonal antibodies (MoAbs), which combine high specificity and low toxicity, would seem to be ideal candidates for Ehrlich's "magic bullet." However, despite the widespread use of one MoAb product (G oldstein et al. 1985), antibodies... N Lonberg - Springer Berlin Heidelberg 被引量: 11...
The invention concerns antibodies to special forms of enzymatically non-active precursors of prostate specific antigen (PSA), their production, their use in immunoassays for determination of [−5, −6, −7] proPSA and the use of measured values from these assays for improved diagnostics in ...
Compositions and methods of therapy for treating diseases mediated by stimulation of CD40 signaling on CD40-expressing cells are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need ...